{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Bodywell%20Natural%20Skin%20Care%20Inc.","name":"Bodywell Natural Skin Care Inc.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-05T16:30:11.370Z"},"count":1,"matches":[{"id":"93cce9d111066ca3","posted_date":"2024-04-02","letter_issue_date":"2024-03-27","company_name":"Bodywell Natural Skin Care Inc.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug","canonical_url":"https://api.morvs.ai/fda-warning/93cce9d111066ca3"}]}